Author Title [ Type(Desc)] Year
Filters: Author is Kalhs, Peter  [Clear All Filters]
Journal Article
Strobl J, Pandey RVinay, Kausgruber T, Kleißl L, Reininger B, Herac M, Bayer N, Krall C, Wohlfarth P, Mitterbauer M, et al. Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease. J Invest Dermatol. 2020.
Brüggen M-C, Klein I, Greinix H, Bauer W, Kuzmina Z, Rabitsch W, Kalhs P, Petzelbauer P, Knobler R, Stingl G, et al. Diverse T cell responses characterize the different manifestations of cutaneous graft-versus-host disease. Blood. 2013.
Brüggen M-C, Petzelbauer P, Greinix H, Contassot E, Jankovic D, French L, Socié G, Rabitsch W, Kuzmina Z, Kalhs P, et al. Epidermal Elafin Expression is an Indicator of Poor Prognosis in Cutaneous Graft-versus-Host Disease. J Invest Dermatol. 2014.
Rodríguez-Arbolí E, Labopin M, Tischer J, Brecht A, Ganser A, Finke J, Blau IWolfgang, Kröger N, Kalhs P, Forcade E, et al. FLAMSA-based reduced intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the time of allogeneic stem cell transplantation: an ALWP/EBMT analysis. Biol Blood Marrow Transplant. 2020.
Bojic M, Berghoff AS, Troch M, Agis H, Sperr WR, Widhalm G, Wöhrer A, Kalhs P, Preusser M, Rabitsch W. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: Single centre experience and literature review. Eur J Haematol. 2014.